Uzm. Dr.Kübra Kızıltaç

  • İlgi Alanları
  • Ürtiker
  • Kozmetik dermatoloji
  • Lazer

Eğitim ve Uzmanlık
2007 - 2013 - Cerrahpaşa Tıp Fakültesi - Tıp eğitimi
2013 - 2018 - Okmeydanı Eğitim ve Araştırma Hastanesi - Uzmanlık

Deneyim
2018 - 2019 - Adıyaman Kahta Devlet Hastanesi
2019 - Okmeydanı Eğitim ve Araştırma Hastanesi

Mesleki Üyelikler
Türk Dermatoloji Derneği
Türk TAbipler Birliği
European Academy of Dermatology and Venereology
Deri ve Zührevi Hastalıkları Derneği
 

Uluslararası hakemli dergilerde yayımlanan makaleler:

1. When Does the Dermatologists Suspect Diabetes Mellitus? Nagihan Tarıkcı, Emek Kocatürk, Utkan Kızıltaç, Kübra Cüre, Hatice Ergün, Bachar Memet. Okmeydanı Tıp Dergisi 31(Ek sayı ): 33-38.2015

  1. 2. Dapsone-induced methemoglobinemia in a patient with wells syndrome:a case report.         Orkide Kutlu, Emek Özgür Kocatürk, Kübra Cüre, Cuyan Demirkesen, Hasan Eruzun, Tufan Tükek. J Ist Faculty Med 2016; 79: 2
     
  2. 3. Generalized Bullous Fixed Drug Eruption: Case Report. Hatice DUMAN, İlteriş Oğuz TOPAL, Kübra CÜRE, Emek KOCATÜRK. Turkiye Klinikleri J Dermatol 2016;26(2):121-4
  3. 4. A maculopapular and pustular rash followed by erythema multiforme in a patient treated with hydroxychloroquine. Hatice Duman, İlteriş Oğuz TOPAL, Kübra CÜRE, Emek Kocatürk, Çağlar Çakır. Nobel Medicus Journal 12.2 (2016)

 

  1. 5. Becker nevus on the face: A rare presentation. Ece Nur Yuksel, Emek Kocaturk, Hatice Duman, Ayşe Seza Kunter, Kübra Cüre, Özlem Korkmaz. Türkiye Klinikleri J Dermatol. (2016)   doi: 10.5336/dermato.2016-50793
  2. 6.. Duman, H., Oğuz Topal, İ., Cüre, K., Kocatürk, E., & Özekinci, S. Extradigital glomus tumor: a case report.
  3. 7  Facial Hyperpigmentations and Their Management. Kübra Cüre, Emek Kocatürk, Utkan Kızıltaç.   Okmeydanı Tıp Dergisi 32(4): 211-218, 2016. doi:10.5222/otd.2016.1069 .
  4. 8. Turk M, Kocaturk E, Cure K, Yilmaz I. Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria. J Allergy Clin Immunol Pract. 2018;
  5. 9.Oğuz Topal, İ., Değirmentepe, E., Cüre, K., Kızıltaç, U., Bahçetepe Hökenek, N., & Kocatürk, E. (2017). Retrospective analysis of clinical and sociodemographic features of patients with psoriasis.
  6. 10.Singer, R., Demirel, N., Yüksel, T., Kızıltac, K., & Tanrıtanır, R. (2019). Science Repository.

 

  1. 11. Cüre, K., Kocatürk, E., Koku Aksu, A. E., Yüksel, T., Leblebici, C., Özekinci, S., ... & Değirmentepe, E. (2017). Brooke–Spiegler syndrome: focus on reflectance confocal microscopy findings of trichoepithelioma and flat cylindroma. Clinical and experimental dermatology42(8), 906-909.
  2. 12.Singer, R., Örken, C., Güngör, Ş., Çopur, M., Kızıltaç, U., Kızıltaç, K., ... & Erhan, S. Ş. (2019). Polyneuropathy developing after infliximab therapy in a patient with recalcitrant pyoderma gangrenosum. Turkish Archives of Dermatology & Venerology/Turkderm53(1).

13. Kocatürk, E., Kızıltaç, U., Can, P., Kara, R. Ö., Erdem, T., Kızıltaç, K., ... & Weller, K. (2019). Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria. World Allergy Organization Journal12(1), 100009.

 

14. Degirmentepe, E. N., Kızıltac, K., Etikan, P., Singer, R., Memet, B., & Kocaturk, E. (2019). Omalizumab as a Succesfull Therapy in Normocomplementemic Urticarial Vasculitis: A Series of Four Patients and Review of the Literature. Annals of Dermatology31(3), 335-338.

 

15.GÖNCÜ, Emek Kocatürk; KIZILTAÇ, Kübra; LESLIE, Tabi. Omalizumab in chronic urticaria: A comprehensive review. Turkish Archives of Dermatology & Venerology/Turkderm, 2018, 52.4.

 

16.Can, P. K., Etikan, P., Kızıltaç, U., Kızıltaç, K., Singer, R., & Kocaturk, E. (2019). Fric Test Revisited: A Suggestion for a New Scoring System and Its Correlation with Urticaria Control Test and Dermatology Life Quality Index. International archives of allergy and immunology178(1), 76-82.

 

17.Kocatürk, E., Deza, G., Kızıltaç, K., & Giménez-Arnau, A. M. (2018). Omalizumab updosing for better disease control in chronic spontaneous urticaria patients. International archives of allergy and immunology177(4), 360-364.

 

18.Kocatürk, E., Can, P. K., Akbas, P. E., Copur, M., Degirmentepe, E. N., Kızıltac, K., & Singer, R. (2017). Management of chronic inducible urticaria according to the guidelines: a prospective controlled study. Journal of dermatological science87(1), 60-69.

 

19. Ornek, S. A. Kuteyla Can P, Degirmentepe EN, Kiziltac K, Gungor S, Oguz Topal I, et al. Periorbital Dermatitis: The Role of Type1.